Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lepu Biopharma Co., Ltd. has announced a proposed change of auditor, with PricewaterhouseCoopers resigning and the company planning to appoint Ernst & Young as its new auditor for 2024. This transition, recommended by the Audit Committee, is pending approval at the upcoming extraordinary general meeting and is based on Ernst & Young’s industry experience and market reputation.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.